Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy
The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT). Stage II RAP secondary to age-related macular degeneration was docum...
Gespeichert in:
Veröffentlicht in: | Graefe's archive for clinical and experimental ophthalmology 2006-11, Vol.244 (11), p.1528-1533 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1533 |
---|---|
container_issue | 11 |
container_start_page | 1528 |
container_title | Graefe's archive for clinical and experimental ophthalmology |
container_volume | 244 |
creator | Bottoni, Ferdinando Romano, Mary Massacesi, Amedeo Bergamini, Fulvio |
description | The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT).
Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later.
Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible.
Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration. |
doi_str_mv | 10.1007/s00417-006-0311-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68126804</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68126804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</originalsourceid><addsrcrecordid>eNpdkc9q3DAQh0VpababPkAvRfTQm5uRbMv2sYT0DwQKoYHcxFgeZxVkaSvJKfsefeBq2YVCTxKj7zdi5mPsnYBPAqC7SgCN6CoAVUEtRDW8YBvR1G3VgXx4yTbQSVH1tXy4YG9SeoKC1614zS6EUjAM0GzYnztawkTO-kceZp53xJ8xmdVh5GaH3pNL3HoeKVuPjqN_tGHBHNbE9zE4O1PEbINPPEfCTBP_bfOuRHLEZ3usufJicTHWBxc8cTSUg7dTufmJ73chh-ngcbHm-H3E_eGSvZrRJXp7Prfs_svNz-tv1e2Pr9-vP99WppYqV51AYwz0QyNbNasWpsZIWYrN3LR9P85A0ziQGnuU7Sz6xpjOFBJaNUrqVb1lH099yyS_VkpZLzYZcg49lQG16oVUfVnaln34D3wKayz7SFrW0BVEigKJE2RiSCnSrPfRLhgPWoA--tInX7r40kdfeiiZ9-fG67jQ9C9xFlT_BQoYlRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230780421</pqid></control><display><type>article</type><title>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Bottoni, Ferdinando ; Romano, Mary ; Massacesi, Amedeo ; Bergamini, Fulvio</creator><creatorcontrib>Bottoni, Ferdinando ; Romano, Mary ; Massacesi, Amedeo ; Bergamini, Fulvio</creatorcontrib><description>The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT).
Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later.
Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible.
Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.</description><identifier>ISSN: 0721-832X</identifier><identifier>EISSN: 1435-702X</identifier><identifier>DOI: 10.1007/s00417-006-0311-9</identifier><identifier>PMID: 16609904</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Aged ; Aged, 80 and over ; Coloring Agents ; Drug Therapy, Combination ; Female ; Fluorescein Angiography ; Glucocorticoids - therapeutic use ; Humans ; Indocyanine Green ; Injections ; Macular Degeneration - complications ; Male ; Photochemotherapy ; Regional Blood Flow - physiology ; Retinal Neovascularization - drug therapy ; Retinal Neovascularization - etiology ; Retinal Neovascularization - physiopathology ; Retinal Vessels - physiology ; Triamcinolone Acetonide - therapeutic use ; Vitreous Body</subject><ispartof>Graefe's archive for clinical and experimental ophthalmology, 2006-11, Vol.244 (11), p.1528-1533</ispartof><rights>Springer-Verlag 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</citedby><cites>FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16609904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bottoni, Ferdinando</creatorcontrib><creatorcontrib>Romano, Mary</creatorcontrib><creatorcontrib>Massacesi, Amedeo</creatorcontrib><creatorcontrib>Bergamini, Fulvio</creatorcontrib><title>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</title><title>Graefe's archive for clinical and experimental ophthalmology</title><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><description>The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT).
Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later.
Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible.
Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Coloring Agents</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Fluorescein Angiography</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Indocyanine Green</subject><subject>Injections</subject><subject>Macular Degeneration - complications</subject><subject>Male</subject><subject>Photochemotherapy</subject><subject>Regional Blood Flow - physiology</subject><subject>Retinal Neovascularization - drug therapy</subject><subject>Retinal Neovascularization - etiology</subject><subject>Retinal Neovascularization - physiopathology</subject><subject>Retinal Vessels - physiology</subject><subject>Triamcinolone Acetonide - therapeutic use</subject><subject>Vitreous Body</subject><issn>0721-832X</issn><issn>1435-702X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkc9q3DAQh0VpababPkAvRfTQm5uRbMv2sYT0DwQKoYHcxFgeZxVkaSvJKfsefeBq2YVCTxKj7zdi5mPsnYBPAqC7SgCN6CoAVUEtRDW8YBvR1G3VgXx4yTbQSVH1tXy4YG9SeoKC1614zS6EUjAM0GzYnztawkTO-kceZp53xJ8xmdVh5GaH3pNL3HoeKVuPjqN_tGHBHNbE9zE4O1PEbINPPEfCTBP_bfOuRHLEZ3usufJicTHWBxc8cTSUg7dTufmJ73chh-ngcbHm-H3E_eGSvZrRJXp7Prfs_svNz-tv1e2Pr9-vP99WppYqV51AYwz0QyNbNasWpsZIWYrN3LR9P85A0ziQGnuU7Sz6xpjOFBJaNUrqVb1lH099yyS_VkpZLzYZcg49lQG16oVUfVnaln34D3wKayz7SFrW0BVEigKJE2RiSCnSrPfRLhgPWoA--tInX7r40kdfeiiZ9-fG67jQ9C9xFlT_BQoYlRs</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Bottoni, Ferdinando</creator><creator>Romano, Mary</creator><creator>Massacesi, Amedeo</creator><creator>Bergamini, Fulvio</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20061101</creationdate><title>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</title><author>Bottoni, Ferdinando ; Romano, Mary ; Massacesi, Amedeo ; Bergamini, Fulvio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Coloring Agents</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Fluorescein Angiography</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Indocyanine Green</topic><topic>Injections</topic><topic>Macular Degeneration - complications</topic><topic>Male</topic><topic>Photochemotherapy</topic><topic>Regional Blood Flow - physiology</topic><topic>Retinal Neovascularization - drug therapy</topic><topic>Retinal Neovascularization - etiology</topic><topic>Retinal Neovascularization - physiopathology</topic><topic>Retinal Vessels - physiology</topic><topic>Triamcinolone Acetonide - therapeutic use</topic><topic>Vitreous Body</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bottoni, Ferdinando</creatorcontrib><creatorcontrib>Romano, Mary</creatorcontrib><creatorcontrib>Massacesi, Amedeo</creatorcontrib><creatorcontrib>Bergamini, Fulvio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bottoni, Ferdinando</au><au>Romano, Mary</au><au>Massacesi, Amedeo</au><au>Bergamini, Fulvio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</atitle><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>244</volume><issue>11</issue><spage>1528</spage><epage>1533</epage><pages>1528-1533</pages><issn>0721-832X</issn><eissn>1435-702X</eissn><abstract>The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT).
Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later.
Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible.
Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>16609904</pmid><doi>10.1007/s00417-006-0311-9</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0721-832X |
ispartof | Graefe's archive for clinical and experimental ophthalmology, 2006-11, Vol.244 (11), p.1528-1533 |
issn | 0721-832X 1435-702X |
language | eng |
recordid | cdi_proquest_miscellaneous_68126804 |
source | MEDLINE; SpringerLink Journals |
subjects | Aged Aged, 80 and over Coloring Agents Drug Therapy, Combination Female Fluorescein Angiography Glucocorticoids - therapeutic use Humans Indocyanine Green Injections Macular Degeneration - complications Male Photochemotherapy Regional Blood Flow - physiology Retinal Neovascularization - drug therapy Retinal Neovascularization - etiology Retinal Neovascularization - physiopathology Retinal Vessels - physiology Triamcinolone Acetonide - therapeutic use Vitreous Body |
title | Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A25%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Remodeling%20of%20the%20vascular%20channels%20in%20retinal%20angiomatous%20proliferations%20treated%20with%20intravitreal%20triamcinolone%20acetonide%20and%20photodynamic%20therapy&rft.jtitle=Graefe's%20archive%20for%20clinical%20and%20experimental%20ophthalmology&rft.au=Bottoni,%20Ferdinando&rft.date=2006-11-01&rft.volume=244&rft.issue=11&rft.spage=1528&rft.epage=1533&rft.pages=1528-1533&rft.issn=0721-832X&rft.eissn=1435-702X&rft_id=info:doi/10.1007/s00417-006-0311-9&rft_dat=%3Cproquest_cross%3E68126804%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230780421&rft_id=info:pmid/16609904&rfr_iscdi=true |